These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

321 related articles for article (PubMed ID: 30710346)

  • 41. Management of medication overuse (MO) and medication overuse headache (MOH) S1 guideline.
    Diener HC; Kropp P; Dresler T; Evers S; Förderreuther S; Gaul C; Holle-Lee D; May A; Niederberger U; Moll S; Schankin C; Lampl C
    Neurol Res Pract; 2022 Aug; 4(1):37. PubMed ID: 36031642
    [TBL] [Abstract][Full Text] [Related]  

  • 42. [Addictive behaviour in medication overuse headache: A review of recent data].
    Radat F; Lanteri-Minet M
    Rev Neurol (Paris); 2011; 167(8-9):568-78. PubMed ID: 21513963
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Prevalence of chronic headache with and without medication overuse: associations with socioeconomic position and physical and mental health status.
    Westergaard ML; Glümer C; Hansen EH; Jensen RH
    Pain; 2014 Oct; 155(10):2005-13. PubMed ID: 25020001
    [TBL] [Abstract][Full Text] [Related]  

  • 44. The Many Faces of Medication-Overuse Headache in Clinical Practice.
    Vandenbussche N; Paemeleire K; Katsarava Z
    Headache; 2020 May; 60(5):1021-1036. PubMed ID: 32232847
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Medication overuse headache: an overview of clinical aspects, mechanisms, and treatments.
    Krymchantowski AV; Jevoux CC; Krymchantowski AG; Vivas RS; Silva-Néto R
    Expert Rev Neurother; 2020 Jun; 20(6):591-600. PubMed ID: 32463304
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Complete withdrawal is the most feasible treatment for medication-overuse headache: A randomized controlled open-label trial.
    Engelstoft IMS; Carlsen LN; Munksgaard SB; Nielsen M; Jensen RH; Bendtsen L
    Eur J Pain; 2019 Jul; 23(6):1162-1170. PubMed ID: 30793412
    [TBL] [Abstract][Full Text] [Related]  

  • 47. A two years open-label prospective study of OnabotulinumtoxinA 195 U in medication overuse headache: a real-world experience.
    Negro A; Curto M; Lionetto L; Martelletti P
    J Headache Pain; 2015; 17():1. PubMed ID: 26792662
    [TBL] [Abstract][Full Text] [Related]  

  • 48. The Evolution of Medication Overuse Headache: History, Pathophysiology and Clinical Update.
    Sun-Edelstein C; Rapoport AM; Rattanawong W; Srikiatkhachorn A
    CNS Drugs; 2021 May; 35(5):545-565. PubMed ID: 34002347
    [TBL] [Abstract][Full Text] [Related]  

  • 49. The impact of COVID-19 pandemic on headache symptoms and drug withdrawal among patients with medication overuse headache: a cross-sectional study.
    Li C; Li Y; Ma M; Zhang Y; Bao J; Ge W; Liu Y; Peng C; He L
    J Headache Pain; 2021 May; 22(1):41. PubMed ID: 34020588
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Impulse control disorders in chronic migraine with medication overuse after onabotulinumtoxinA: A single-center prospective cohort study.
    d'Onofrio F; de Falco A; Costanzo A; Spitaleri D; Casucci G; Raimo S
    J Clin Neurosci; 2020 Oct; 80():152-155. PubMed ID: 33099338
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Severity of Analgesic Dependence and Medication-overuse Headache.
    Lundqvist C; Gossop M; Russell MB; Straand J; Kristoffersen ES
    J Addict Med; 2019; 13(5):346-353. PubMed ID: 30724760
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Clinical features, pathophysiology, and treatment of medication-overuse headache.
    Evers S; Marziniak M
    Lancet Neurol; 2010 Apr; 9(4):391-401. PubMed ID: 20298963
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Circulating nociceptin and CGRP in medication-overuse headache.
    Munksgaard SB; Ertsey C; Frandsen E; Bendtsen L; Tekes K; Jensen RH
    Acta Neurol Scand; 2019 Mar; 139(3):269-275. PubMed ID: 30457160
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Discontinuation of medication overuse in headache patients: recovery of therapeutic responsiveness.
    Zeeberg P; Olesen J; Jensen R
    Cephalalgia; 2006 Oct; 26(10):1192-8. PubMed ID: 16961785
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Medication overuse headache from antimigraine therapy: clinical features, pathogenesis and management.
    Smith TR; Stoneman J
    Drugs; 2004; 64(22):2503-14. PubMed ID: 15516151
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Medication overuse headache: clinical features predicting treatment outcome at 1-year follow-up.
    Zidverc-Trajkovic J; Pekmezovic T; Jovanovic Z; Pavlovic A; Mijajlovic M; Radojicic A; Sternic N
    Cephalalgia; 2007 Nov; 27(11):1219-25. PubMed ID: 17888081
    [TBL] [Abstract][Full Text] [Related]  

  • 57. In medication-overuse headache, fMRI shows long-lasting dysfunction in midbrain areas.
    Ferraro S; Grazzi L; Muffatti R; Nava S; Ghielmetti F; Bertolino N; Mandelli ML; Visintin E; Bruzzone MG; Nigri A; Epifani F; Bussone G; Chiapparini L
    Headache; 2012; 52(10):1520-34. PubMed ID: 23094707
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Treatment of medication-overuse headache: A systematic review.
    Chiang CC; Schwedt TJ; Wang SJ; Dodick DW
    Cephalalgia; 2016 Apr; 36(4):371-86. PubMed ID: 26122645
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Clinical and Demographical Characteristics of Patients with Medication Overuse Headache in Argentina and Chile: Analysis of the Latin American Section of COMOESTAS Project.
    Shand B; Goicochea MT; Valenzuela R; Fadic R; Jensen R; Tassorelli C; Nappi G;
    J Headache Pain; 2015; 16():83. PubMed ID: 26382855
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Past, present, and future prospects of medication-overuse headache classification.
    Ferrari A; Coccia C; Sternieri E
    Headache; 2008 Jul; 48(7):1096-102. PubMed ID: 18687082
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 17.